Double-punch strategy shows promise against brain cancer
Glioblastoma, the most aggressive primary brain cancer, remains notoriously difficult to control. Its cells do not stay neatly confined within...
Rowan Blackwood covers cancer and oncology, including tumor biology, screening, diagnostics, treatment research, clinical trials, and survivorship science.
Glioblastoma, the most aggressive primary brain cancer, remains notoriously difficult to control. Its cells do not stay neatly confined within...
Dr. Cristina Puig-Saus and her research team at the UCLA Health Jonsson Comprehensive Cancer Center have received a five-year, $3.9...
Cancer researchers have unveiled one of the most extensive collections of patient-derived tumor models ever assembled, creating a living laboratory...
Memorial Sloan Kettering Cancer Center researchers have identified a protein that appears to control one of the gut’s most important...
Cancer researchers have designed a synthetic peptide that turns tumour cells into highly visible targets for the immune system by...
Boston researchers and international collaborators have unveiled a landmark cancer research resource: 665 next-generation patient-derived models representing 27 common and...
Scientists have created nearly 700 new cancer models from patient tumors, delivering one of the largest publicly available collections of...
Cancer research is entering a new phase in which tumors are no longer viewed as isolated collections of malignant cells....
A comprehensive review published in Genes & Diseases is drawing renewed attention to FOXK2, a transcription factor that may help...
Cancer research is entering an era in which tumors are no longer viewed as isolated masses of abnormal human cells....
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine